Drug Shortage Report for ETOPOSIDE INJECTION

Last updated on 2020-03-16 History
Report ID 68626
Drug Identification Number 02080036
Brand name ETOPOSIDE INJECTION
Common or Proper name ETOPOSIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ETOPOSIDE
Strength(s) 20MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10ML
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-04
Estimated end date 2020-03-31
Actual end date 2020-03-15
Shortage status Resolved
Updated date 2020-03-16
Company comments Out of stock
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-12-12 French Compare
v4 2018-12-12 English Compare
v3 2018-12-05 English Compare
v2 2018-12-04 French Compare
v1 2018-12-04 English Compare

Showing 21 to 25 of 25